Frontiers in Immunology · 2022 · 10 citations · 15 references
Life SciencesImmunologyNeurologyAutoimmunityImmunopathologyNeuroimmunologyAutoimmune DiseasesAutoimmune Neurological DisordersDemyelinating DiseasesDemyelinating DisordersEncephalitisNeuropathology Of InfectionDemyelinating Lesion PathologyGuillain-barré Syndrome PathogenesisImmune-mediated Demyelination
A severely comatose female patient was diagnosed with Japanese encephalitis (JE). Her condition was complicated by Hashimoto's thyroiditis (HT) and Guillain-Barré syndrome (GBS). After antiviral, glucocorticoid, and immunoglobulin treatment, the patient's consciousness was restored, and she could breathe spontaneously. Following this, new-onset, primarily demyelinating GBS developed, which progressed to demyelination combined with axonal injury. The patient was switched to protein A immunoadsorption (PAIA) therapy, and her Hughes score decreased rapidly, from 4 to 1 after 6 months. This patient is the first to receive PAIA combined with an antiviral-glucocorticoid-immunoglobulin regimen to treat encephalitis, meningitis, HT, and GBS caused by JE infection, thereby reflecting the importance of clinical application of PAIA in the treatment of immunological complications of JE.
15
Autoimmune diseases and HIV infection
Emilie Virot, Antoine Duclos, Léopold Adélaïde et al. · Medicine · 2017 · 96 citations · Full text
Current treatment practice of Guillain-Barré syndrome
Christine Verboon, Alex Y. Doets, Giuliana Galassi et al. · Neurology · 2019 · 88 citations · Full text